OrbiMed’s Agilent Technologies A Stock Holding History

OrbiMed’s Portfolio A Stock Details A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-419,400	Closed	-$15.4M	–	121
2013 Q3	$15.4M	Buy	419,400 +26,143	+7%	+$881K	0.27%	63
2013 Q2	$12M	Buy	+393,257	New	+$12.2M	0.25%	69

Other funds holding A

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

OrbiMed's A Position: Q3 2019 in Review

OrbiMed sold out of Agilent Technologies (A) in Q3 2019, closing a stake of 893,200 shares — an estimated $66.7M sold.

OrbiMed first reported a position in A in Q2 2013 and held it in 25 quarters. The position peaked at $234M in Q3 2017. 699 funds tracked by Wall St. Rank hold A as of Q3 2019.

OrbiMed reported no remaining Agilent Technologies position as of Q3 2019 after selling out during the quarter.
OrbiMed sold 893,200 Agilent Technologies shares in Q3 2019, an estimated $66.7M.
OrbiMed first reported a position in Agilent Technologies in Q2 2013 and held it in 25 quarters.
OrbiMed's Agilent Technologies position peaked at $234M in Q3 2017.
699 funds tracked by Wall St. Rank held Agilent Technologies as of Q3 2019.

Based on OrbiMed's 13F filing for Q3 2019, filed 14 Nov 2019.